Hepatitis and Lupus-Like Syndrome during Infliximab Therapy for Psoriasis
| Autor: | Khalifa Al Naama, Hussein Al Sada, Mariam Al Mansoori, Samya Abu Shaikha, Hamda Al Ansari, Hassan Riad |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2013 |
| Předmět: |
Infliximab therapy
Drug medicine.medical_specialty media_common.quotation_subject Published online: August 2013 Dermatology Disease Hepatitis Internal medicine Psoriasis medicine lcsh:Dermatology skin and connective tissue diseases Lupus-like syndrome media_common business.industry lcsh:RL1-803 medicine.disease Infliximab Rheumatology business medicine.drug |
| Zdroj: | Case Reports in Dermatology, Vol 5, Iss 2, Pp 219-224 (2013) Case Reports in Dermatology |
| ISSN: | 1662-6567 |
| Popis: | Biologics are very useful medications that changed the lives of many patients in the last decade. However, we still do not know about the long-term side effects of these drugs. Infliximab is an anti-TNF chimeric antibody widely used and approved for the treatment of many diseases. Lupus-like syndrome and hepatitis are among the uncommon side effects of infliximab. Most of the written literature was published for cases of rheumatology and gastroenterology. We report here a case of both hepatitis and lupus-like syndrome that occurred sequentially in the same patient and compare our finding with two case reports of the same side effects, drug and disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|